Sign inGet started

FLETCHER MARK

Insider CIK 1229529 · GNBT President,CEO,General Counsel, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2018-10-032018-10-154,500— $04,500SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-162016-02-164,447,111— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise2016-02-162016-02-164,447,111— $015,821,836SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-124,447,111— $04,447,111SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-121,457,195— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-125,143,787— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-121,587,300— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise2016-02-092016-02-1214,890,033— $010,442,992SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2014-10-062014-10-08470,726— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise2014-10-062014-10-08470,726— $0470,726SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-10-312013-11-012,254,640— $02,254,640SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-06-062013-06-101,587,300— $01,587,300SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-04-012013-04-015,143,787— $05,143,787SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2012-06-192012-06-211,457,195— $01,457,195SEC↗